Public Service Enterprise Group Incorporated (LON:0KS2)
81.62
-1.96 (-2.35%)
At close: Oct 2, 2025
LON:0KS2 Revenue
Public Service Enterprise Group had revenue of $2.81B USD in the quarter ending June 30, 2025, with 15.77% growth. This brings the company's revenue in the last twelve months to $11.13B, up 8.69% year-over-year. In the year 2024, Public Service Enterprise Group had annual revenue of $10.29B, down -8.43%.
Revenue (ttm)
$11.13B
Revenue Growth
+8.69%
P/S Ratio
3.74
Revenue / Employee
$853.38K
Employees
13,047
Market Cap
30.37B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10.29B | -947.00M | -8.43% |
Dec 31, 2023 | 11.24B | 1.44B | 14.66% |
Dec 31, 2022 | 9.80B | 78.00M | 0.80% |
Dec 31, 2021 | 9.72B | 119.00M | 1.24% |
Dec 31, 2020 | 9.60B | -473.00M | -4.69% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
National Grid | 18.38B |
SSE plc | 10.13B |
Centrica | 19.50B |
United Utilities Group | 2.15B |
Severn Trent | 2.43B |
Drax Group | 5.65B |
Greencoat UK Wind | -11.51M |
Pennon Group | 1.05B |
Public Service Enterprise Group News
- 10 days ago - PSEG Long Island to Continue Serving Long Island and the Rockaways for the Next Five Years - PRNewsWire
- 4 weeks ago - Correction: Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, receives regulatory approval to initiate pivotal clinical trial with RNX-011 for life-threatening peritonitis - GlobeNewsWire
- 4 weeks ago - Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, receives regulatory approval to initiate pivotal clinical trial with RNX-011 for life-threatening peritonitis - GlobeNewsWire
- 6 weeks ago - Public Service Enterprise: Long-Term Earnings Outlook Remains Very Positive - Seeking Alpha
- 6 weeks ago - A Look Into Public Service Enterprise Inc's Price Over Earnings - Benzinga
- 7 weeks ago - Three Stocks Morgan Stanley Recommends for Playing the ‘Nuclear Renaissance' - Investopedia
- 2 months ago - Public Service Enterprise Group Incorporated (PEG) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Public Service Enterprise Group Incorporated 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha